Recurrence of HCC Following Direct-acting Antiviral Therapy Recurrence of HCC Following Direct-acting Antiviral Therapy
Might direct-acting antivirals increase risk and aggressiveness of hepatocellular carcinoma recurrence? This review aimed to characterize HCC recurrence patterns after DAA therapy.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Direct Antiviral Therapy of Hep C May Not Boost Hepatocellular-Carcinoma Risk Direct Antiviral Therapy of Hep C May Not Boost Hepatocellular-Carcinoma Risk
Treatment of hepatitis C (HCV) with direct-acting antiviral agents does not appear to increase the risk of hepatocellular carcinoma (HCC) in individuals with cirrhosis, researchers from France report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 3, 2018 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Hep C Expert Interview: Gregory T. Everson, MD
Renowned transplant expert Gregory T. Everson, MD, talked with Patient Care about sensitive issues surrounding liver transplant in the era of direct-acting antiviral therapy. (Source: ConsultantLive)
Source: ConsultantLive - August 1, 2018 Category: Internal Medicine Authors: Andrew D. Bowser Tags: Hepatitis C Source Type: news
HCV: 6 Reasons in Favor of Antiviral Therapy During Pregnancy HCV: 6 Reasons in Favor of Antiviral Therapy During Pregnancy
Dr Nancy Reau discusses factors that could potentially support the use of antiviral therapy during pregnancy to prevent mother-to-child transmission of hepatitis C virus infection.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 23, 2018 Category: Consumer Health News Tags: Gastroenterology Commentary Source Type: news
Negative rapid test results may delay antiviral therapy in patients with severe influenza
(American Society for Microbiology) A new study has found that half of influenza cases in patients admitted to the intensive care unit (ICU) received a false negative rapid influenza antigen test (RIAT). The false negative RIAT results could delay antiviral therapy for patients who were in the ICU with severe influenza. The research is presented at ASM Microbe, the American Society for Microbiology's annual meeting, held from June 7-11 in Atlanta, Ga. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 10, 2018 Category: Biology Source Type: news
Liver Stiffness Measurement-Based Approach for HBV Liver Stiffness Measurement-Based Approach for HBV
Decline of liver stiffness from baseline after 1 year of antiviral therapy for HBV infection may reflect remission of liver inflammation and fibrosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 3, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
HBV Treatment Fails to Meet Global Targets (CME/CE)
(MedPage Today) -- Only 5% of hepatitis B patients received antiviral therapy in 2016 (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 26, 2018 Category: Primary Care Source Type: news
Treatment To Prevent Hepatitis C Recurrence After Liver Transplantation
In a clinical trial, researchers found that antiviral therapy prior to a liver transplant can prevent hepatitis C recurrence in some patients. (Source: NIDDK News)
Source: NIDDK News - March 15, 2018 Category: Endocrinology Source Type: news
Hepatitis C Virus Clearance in Older Adults Hepatitis C Virus Clearance in Older Adults
Does HCV clearance with direct-acting antiviral therapy improve outcomes in individuals aged 80 and older--even in the face of severe liver disease and multiple comorbidities?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 21, 2018 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Shortening Duration of Therapy With DAAs for HCV Genotype 1 Shortening Duration of Therapy With DAAs for HCV Genotype 1
Can direct-acting antiviral therapy for hepatitis C genotype 1 be reduced to less than the current standard of 12 weeks without compromising outcomes?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Sofosbuvir Safe, Effective for HCV in Those With CKD Sofosbuvir Safe, Effective for HCV in Those With CKD
Sofosbuvir-based antiviral therapy cured hepatitis C virus infection in more than 80% of patients with chronic kidney disease, a retrospective cohort study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 15, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Treating a little-known virus, CMV, to combat hearing loss in children
(University of Utah Health) A National Institutes of Health-supported nationwide clinical trial will test a novel approach to combat hearing loss in children infected by a relatively unknown virus, cytomegalovirus (CMV). The University of Utah Health-led study will determine whether antiviral therapy can halt progressive hearing loss in children with a confirmed CMV infection. CMV is the leading non-genetic cause of hearing loss, contributing from 6 to 30 percent of childhood cases. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 14, 2017 Category: Infectious Diseases Source Type: news
Antiviral Therapy in Patients With Influenza Antiviral Therapy in Patients With Influenza
Which patients should receive antiviral therapy for influenza, and what are the currently available options?U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 22, 2017 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news
Subcirrhotic Liver Stiffness Cuts HCC Risk in Hepatitis B
Achievement of subcirrhotic range of liver stiffness with antiviral therapy reduces HCC risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 10, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Infections, Internal Medicine, Oncology, Journal, Source Type: news
Antiviral therapy is effective in fighting hepatitis C | Letters
The Cochrane analysis casting doubt on this life-saving therapy is flawed and may deter patients from seeking it, say clinicians and scientistsWe are clinicians and scientists who have studied and treated patients with chronic hepatitis C virus infection over many years and patient groups that represent those affected by hepatitis C. We write in response to your article on the effectiveness of antiviral therapy (Hepatitis ‘wonder drug’ may be clinically ineffective, say experts, 9 June). The Cochrane review that you highlight analysed clinical trials, which are by nature short term, where the sole purpose was to evalua...
Source: Guardian Unlimited Science - June 13, 2017 Category: Science Authors: Letters Tags: Hepatitis C Health Pharmaceuticals industry Medical research Drugs Business Science UK news Society Source Type: news
